This department is offering a grant to support the development and validation of technologies addressing pre-analytical degradation of targeted analytes in cancer-related biospecimens. The aim is to enhance biospecimen quality and utility for cancer research. Applicants need to provide preliminary data justifying technology feasibility. The grant will fund projects developing tools, devices, and methods for sample quality assessment, integrity preservation, and quality control. These innovations are expected to advance research in cancer biology, early detection, clinical diagnosis, and treatment. This opportunity is part of the NCI’s Innovative Molecular Analysis Technologies Program. Closing date: Sep 22, 2015.
Opportunity ID: 271186
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-15-005 |
| Funding Opportunity Title: | Advanced Development and Validation of Emerging Technologies for Cancer-Relevant Biospecimen Science (R33) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 08, 2015 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 22, 2015 |
| Current Closing Date for Applications: | Sep 22, 2015 |
| Archive Date: | Oct 23, 2015 |
| Estimated Total Program Funding: | $800,000 |
| Award Ceiling: | $300,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities For profit organizations other than small businesses State governments Special district governments Small businesses Independent school districts City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) solicits grant applications proposing research projects on the advanced development and validation of technologies that address issues related to pre-analytical degradation of targeted analytes during the collection, processing, handling, and storage of cancer-relevant biospecimens. Applications must include preliminary data sufficient to justify the feasibility of the proposed technology, but may still require additional development to reach a generally useful level of functionality for cancer-related research applications. The overall goal is to support the development of highly innovative technologies capable of interrogating and/or maximizing the quality and utility of biospecimens or samples derived from those biospecimens for downstream analyses. This FOA will support the development of tools, devices, instrumentation, and associated methods to assess sample quality, preserve/protect sample integrity, and establish verification criteria for quality assessment/quality control and handling under diverse conditions. These technologies are expected to potentially accelerate and/or enhance research in cancer biology, early detection, screening, clinical diagnosis, treatment, epidemiology, and cancer health disparities, by reducing pre-analytical variations that affect biospecimen sample quality.
This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-15-005.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-C | FORMS-C | PKG00211473 | Feb 17, 2015 | Sep 22, 2015 | View |
Package 1
Mandatory forms
271186 RR_SF424_2_0-2.0.pdf
271186 PHS398_ResearchPlan_2_0-2.0.pdf
271186 PHS398_CoverPageSupplement_2_0-2.0.pdf
271186 RR_Budget_1_3-1.3.pdf
271186 RR_KeyPersonExpanded_2_0-2.0.pdf
271186 RR_OtherProjectInfo_1_3-1.3.pdf
271186 PerformanceSite_2_0-2.0.pdf
Optional forms
271186 PlannedReport-1.0.pdf
271186 PHS398_CumulativeInclusionReport-1.0.pdf
271186 RR_SubawardBudget30_1_3-1.3.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
